OGA and Insulin resistance: Earlier studies indicated that elevated levels of O-GlcNAcylation—arising from increased expression of O-GlcNAc transferase (OGT) or inhibition of O-GlcNAcase (OGA)—may contribute to insulin resistance via the hexosamine biosynthetic pathway (HBP) (Figure 7E) [155].